The first clinical trial with Afi has started in August 2021 at the Reinier de Graaf Hospital in Delft. In this study people who undergo an electrocardioversion are included. Electrocardioversion is a treatment which is used for people who suffer from ‘atrial fibrillation’, which makes this group very suitable for data collection on this arrhythmia. With the gathered data, Praxa Sense is training and validating its top-of-class Machine Learning algorithm that can be used for automatic diagnosis with minimal required effort of a healthcare professional, which will further unburden healthcare. During the trial, 165 patients will be included. The results will be shared in a paper. Stay tuned!